A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Clinical trial NCT06845202 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06845202
Sponsor: Alnylam Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Obese or Overweight Healthy Volunteers Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-03-03
Primary completion: 2027-08-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.